Humana (HUM) Receivables - Other (2009 - 2022)

Humana (HUM) has 14 years of Receivables - Other data on file, last reported at $1.8 billion in Q4 2022.

• On a quarterly basis, Receivables - Other rose 37.31% year-over-year to $1.8 billion in Q4 2022; TTM through Dec 2022 was $1.8 billion, a 37.31% increase from a year earlier, with the FY2022 full-year figure at $1.8 billion, up 37.31% from the prior year.
• Receivables - Other for Q4 2022 stood at $1.8 billion, up from $1.3 billion in the prior quarter.
• Over the last five years, Receivables - Other for HUM reached as high as $1.8 billion in Q4 2022 and fell as low as $1.2 billion in Q4 2020.
• Historically, Receivables - Other has averaged $1.4 billion across 5 years, with a median of $1.3 billion in 2018.
• Across the five-year window, Receivables - Other fell 4.89% in 2020 and jumped 37.31% in 2022, its largest moves.
• Year by year, Receivables - Other stood at $1.3 billion in 2018, then dropped by 4.44% to $1.2 billion in 2019, then dropped by 4.89% to $1.2 billion in 2020, then climbed by 10.87% to $1.3 billion in 2021, then jumped by 37.31% to $1.8 billion in 2022.
• Per Business Quant data, the three most recent Receivables - Other figures were $1.8 billion in Q4 2022, $1.3 billion in Q4 2021, and $1.2 billion in Q4 2020.